about
Tight glycemic control after pediatric cardiac surgery in high-risk patient populations: a secondary analysis of the safe pediatric euglycemia after cardiac surgery trialWhite matter microstructure and cognition in adolescents with congenital heart diseaseProspective evaluation of sedation-related adverse events in pediatric patients ventilated for acute respiratory failure.Validity and generalizability of the Withdrawal Assessment Tool-1 (WAT-1) for monitoring iatrogenic withdrawal syndrome in pediatric patientsTight Glycemic Control With Insulin Does Not Affect Skeletal Muscle Degradation During the Early Postoperative Period Following Pediatric Cardiac Surgery.Tight glycemic control versus standard care after pediatric cardiac surgery.Patterns of Sedation Weaning in Critically Ill Children Recovering From Acute Respiratory Failure.Early High-Frequency Oscillatory Ventilation in Pediatric Acute Respiratory Failure. A Propensity Score Analysis.Impact of Tight Glycemic Control on Neurodevelopmental Outcomes at 1 Year of Age for Children with Congenital Heart Disease: A Randomized Controlled Trial.Adolescents with D-transposition of the great arteries repaired in early infancy demonstrate reduced white matter microstructure associated with clinical risk factorsProtocolized sedation vs usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial.Subtle hemorrhagic brain injury is associated with neurodevelopmental impairment in infants with repaired congenital heart disease.Sedation Management in Children Supported on Extracorporeal Membrane Oxygenation for Acute Respiratory Failure.Acute Kidney Injury After Pediatric Cardiac Surgery: A Secondary Analysis of the Safe Pediatric Euglycemia After Cardiac Surgery Trial.Tight Glycemic Control in Critically Ill Children.Suspected Cerebral Edema in Diabetic Ketoacidosis: Is There Still a Role for Head CT in Treatment Decisions?White Matter Volume Predicts Language Development in Congenital Heart Disease.Dexmedetomidine Use in Critically Ill Children With Acute Respiratory Failure.Accuracy of an Extubation Readiness Test in Predicting Successful Extubation in Children With Acute Respiratory Failure From Lower Respiratory Tract Disease.Patient, Process, and System Predictors of Iatrogenic Withdrawal Syndrome in Critically Ill Children.Design and rationale of Heart and Lung Failure - Pediatric INsulin Titration Trial (HALF-PINT): A randomized clinical trial of tight glycemic control in hyperglycemic critically ill children.Nurse decision making regarding the use of analgesics and sedatives in the pediatric cardiac ICU.Long-term Outcomes After Protocolized Sedation vs Usual Care in Ventilated Pediatric Patients.Multiple Organ Dysfunction in Children Mechanically Ventilated for Acute Respiratory Failure.Parent presence during invasive procedures and resuscitation: evaluating a clinical practice change.Face and content validity of variables associated with the difficult-to-sedate child in the paediatric intensive care unit: A survey of paediatric critical care clinicians.Altered Gray Matter in Adolescents with d-Transposition of the Great Arteries.The authors replyPhysiologic response to pre-arrest bolus dilute epinephrine in the pediatric intensive care unitThe authors replyRisk Factors for Functional Decline and Impaired Quality of Life after Pediatric Respiratory Failure
P50
Q33707011-2F2BD1DD-3206-47EB-A8A3-970AD4F04CFAQ34643985-53768DF3-A133-4CCA-94D9-A51A413360E7Q35654695-59B69E1E-72AA-4DF1-84D6-DB141E5CA13CQ35662906-46EC6455-FF7E-417F-BEDF-10C452DC5A37Q35836522-2F6EFE1E-FD2F-4158-96E9-16F5F37A8842Q36409992-ADAE4A5C-53B2-45AF-A352-F93646326F1BQ36437272-6CBF2FBF-BACB-4033-96DB-1714D91247DAQ36778539-7A9FDEEB-A2B9-4564-BFDC-985FE3080660Q37048004-DB2B3AC2-3BC0-43C4-B377-B7F4DBE4E37DQ37107210-BF38A182-39E1-4A09-86BF-ADA81D1A6EFFQ37114012-B990E73F-0044-49B6-AA9A-1C3F8A6585B7Q37364704-9843A7B2-C8B8-4D0D-9A91-E362564B144BQ38725892-5D4A56C5-DE28-4355-9061-C1E32ADD11D8Q38792992-FBADF3CB-3629-4D2A-B82F-6D9ACE30B479Q39001624-9DF8E1F5-E52E-4BE2-A655-30D280F60FB3Q39009882-7A116713-68C6-4166-BA4B-B382E3E7D3F3Q39192901-84F5827B-DA6C-4BCE-9B50-FB86FB312CBAQ39365412-911F6534-FA59-4A8D-B98B-9726F3DE4E9EQ39385921-491CB772-F6CB-499E-A52F-975B99843B9EQ39500199-21E26C2F-971B-4DE6-9124-FCB64C382ACCQ40388971-8DDC3FE0-2D8D-4AE1-B23B-5F49713FFAB8Q42674975-3A526228-E339-460D-8615-D289148BB1C7Q47662691-5098ECED-0343-4E05-8D22-87F3DCF40C5FQ47971534-529BD89E-F9E3-4431-904B-0C65519A4F6DQ50783979-A4250C8C-E4BF-4A12-A40B-744B7176E94FQ51556508-E62B1480-5B64-480B-9792-6CB0BE60E11AQ52146980-77CDE586-028C-4A33-A387-54D70C526C4FQ58823339-23699AD0-7E2A-48CC-AD8E-8D16EE350CCFQ59510262-E6DEAB7E-8E08-499F-815E-8BE1C81DA3FBQ59510265-AB496CA3-F298-4034-BF5E-336124392F9EQ91601448-472F8542-36DE-451E-99E8-5A4D3143F5AE
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lisa A. Asaro
@ast
Lisa A. Asaro
@en
Lisa A. Asaro
@es
Lisa A. Asaro
@nl
Lisa A. Asaro
@sl
type
label
Lisa A. Asaro
@ast
Lisa A. Asaro
@en
Lisa A. Asaro
@es
Lisa A. Asaro
@nl
Lisa A. Asaro
@sl
altLabel
Lisa Scoppettuolo
@en
prefLabel
Lisa A. Asaro
@ast
Lisa A. Asaro
@en
Lisa A. Asaro
@es
Lisa A. Asaro
@nl
Lisa A. Asaro
@sl
P106
P1153
16647306300
56076555800
P21
P31
P496
0000-0001-5736-0304